Endomag
Generated by Meeveem AI
"Magnetic surgical guidance platform making breast cancer surgery more precise and less invasive"
Cambridge
•51 - 250 Employees
•Medical Devices
About Endomag
Endomag develops magnetic sensing technologies that guide surgeons during breast cancer procedures. The company's Sentimag platform combines wireless localization markers and lymphatic tracers, eliminating the need for radioactive materials and wires while enabling more accurate tumour removal and staging. Over 1,350 hospitals in 45 countries use these tools to treat patients. The technology allows physicians to de-escalate treatment when appropriate, preventing unnecessary surgeries while improving outcomes for those who need intervention. Founded from university research in 2007 and acquired by Hologic in 2024, Endomag's products have now supported over 500,000 women through breast cancer treatment.
155
Team Members
2007
Founded
Medical Devices
Sector
On-Site
Work Environment
Our Vision
Every woman diagnosed with breast cancer receives the most precise, least invasive surgical care available, regardless of where she is treated in the world.
Our Mission
Endomag improves breast cancer care by preventing unnecessary surgery, improving surgical outcomes with precise and less invasive tools, and increasing global patient access to the best standard of care.